Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.
暂无分享,去创建一个
Mara Cercignani | Lluís Ramió-Torrentà | David H. Miller | Alan J Thompson | Jaume Sastre-Garriga | A. Thompson | M. Cercignani | D. Chard | J. Sastre-Garriga | L. Ramió-Torrentá | David H Miller | Declan T Chard | G. Ingle | Gordon T Ingle | David H. Miller | A. Thompson | A. Thompson
[1] F. Barkhof,et al. Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.
[2] Stephen M. Smith,et al. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.
[3] A. Thompson,et al. One year follow up study of primary and transitional progressive multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.
[4] J. Udupa,et al. The effect of gadolinium-enhancing lesions on whole brain atrophy in relapsing-remitting MS , 2000, Neurology.
[5] A J Thompson,et al. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.
[6] M Rovaris,et al. Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications. , 2001, Brain : a journal of neurology.
[7] B. Trapp,et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.
[8] T. Perneger. What's wrong with Bonferroni adjustments , 1998, BMJ.
[9] David H. Miller,et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. , 2002, Brain : a journal of neurology.
[10] J H Simon,et al. Eight-year follow-up study of brain atrophy in patients with MS , 2002, Neurology.
[11] B. Trapp,et al. Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients , 2003, Journal of neuropathology and experimental neurology.
[12] Ludwig Kappos,et al. Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis. , 2003, Archives of neurology.
[13] A J Thompson,et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. , 1996, Brain : a journal of neurology.
[14] C. Pozzilli,et al. The Relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis , 2004, Journal of Neurology.
[15] R. Rudick,et al. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS , 1999, Neurology.
[16] Stephen M. Rao,et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. , 1999, Brain : a journal of neurology.
[17] P. M. Matthews,et al. Evidence of early cortical atrophy in MS , 2003, Neurology.
[18] A. Kermode,et al. Serial Gd-DTPA MRI reveals differences between primary and secondary progressive multiple sclerosis , 1989 .
[19] J. Baskerville,et al. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.
[20] A J Thompson,et al. Diagnostic criteria for primary progressive multiple sclerosis: A position paper , 2000, Annals of neurology.
[21] B Bass,et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. , 1989, Brain : a journal of neurology.
[22] A. Goldszal,et al. Estimating cerebral atrophy in multiple sclerosis patients from various MR pulse sequences , 2002, Multiple sclerosis.
[23] J. Baskerville,et al. The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.
[24] Massimo Filippi,et al. Disturbed function and plasticity in multiple sclerosis as gleaned from functional magnetic resonance imaging. , 2003, Current opinion in neurology.
[25] A J Thompson,et al. Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis , 2003, Multiple sclerosis.
[26] F. Barkhof,et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. , 1998, Brain : a journal of neurology.
[27] David H. Miller,et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.
[28] G. Comi,et al. Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[29] F. Barkhof,et al. Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype. , 2002, Archives of neurology.
[30] M. A. Horsfield,et al. Whole-brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences , 2003, Journal of the Neurological Sciences.
[31] Alan J Thompson,et al. The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM‐based segmentation methodology , 2002, Journal of magnetic resonance imaging : JMRI.
[32] A J Thompson,et al. A comparison of the pathology of primary and secondary progressive multiple sclerosis. , 1994, Brain : a journal of neurology.
[33] Alan J. Thompson,et al. Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis , 2004, NeuroImage.
[34] A. Thompson,et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis , 1991, Annals of neurology.
[35] M. Rovaris,et al. Quantitative brain volumetric analysis from patients with multiple sclerosis: a follow-up study , 1999, Journal of the Neurological Sciences.